{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:05:59Z","timestamp":1791839159549,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04519-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:11:37Z","timestamp":1764169897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A five-year retrospective analysis of antimicrobial resistance patterns in clinical bacterial isolates from the Jazeera University Laboratory in Mogadishu, Somalia"],"prefix":"10.1186","volume":"25","author":[{"given":"Abdirahman Moallim","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lul Mohamud","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Dahir H.","family":"Aweis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiyo Qasim","family":"Fidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhia Abdullahi","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiyo Mohamed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadumo Abdi","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail Ali","family":"Mohamud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naciima Mohamud","family":"Roble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian Muse","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi Mohamed","family":"Mohamud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadaq Adan","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdiwahab Sheikh Elmi","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi Adan","family":"Shaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"4519_CR1","unstructured":"Habboush Y, Guzman N. Antibiotic Resistance. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513277\/. Cited 2025 May 25."},{"key":"4519_CR2","unstructured":"NFID. Antibiotic Resistance - NFID. https:\/\/www.nfid.org\/. Available from: https:\/\/www.nfid.org\/. Cited 2025 May 25."},{"key":"4519_CR3","unstructured":"WHO. Antimicrobial resistance. 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Cited 2025 May 25."},{"issue":"5","key":"4519_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3201\/eid2305.161556","volume":"23","author":"R Gaynes","year":"2017","unstructured":"Gaynes R. The discovery of Penicillin\u2014New insights after more than 75 years of clinical use. Emerg Infect Dis. 2017;23(5):849\u201353.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"4519_CR5","doi-asserted-by":"publisher","first-page":"e065006","DOI":"10.1136\/bmjopen-2022-065006","volume":"13","author":"M Sijbom","year":"2023","unstructured":"Sijbom M, B\u00fcchner FL, Saadah NH, Numans ME, de Boer MGJ. Determinants of inappropriate antibiotic prescription in primary care in developed countries with general practitioners as gatekeepers: a systematic review and construction of a framework. BMJ Open. 2023;13(5):e065006.","journal-title":"BMJ Open"},{"key":"4519_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0213-005X(13)70126-5","volume":"31","author":"R Cant\u00f3n","year":"2013","unstructured":"Cant\u00f3n R, Horcajada JP, Oliver A, Garbajosa PR, Vila J. Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance. Enfermedades Infecc Microbiol Cl\u00ednica. 2013;31:3\u201311.","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"key":"4519_CR7","doi-asserted-by":"crossref","unstructured":"Lin L, Sun R, Yao T, Zhou X, Harbarth S. Factors influencing inappropriate use of antibiotics in outpatient and community settings in China: a mixed-methods systematic review. BMJ Glob Health. 2020;5(11). Available from: https:\/\/gh.bmj.com\/content\/5\/11\/e003599. Cited 2025 May 25.","DOI":"10.1136\/bmjgh-2020-003599"},{"issue":"10325","key":"4519_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"issue":"10459","key":"4519_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"key":"4519_CR10","doi-asserted-by":"crossref","unstructured":"Fongang H, Mbaveng AT, Kuete V. Chapter One - Global burden of bacterial infections and drug resistance. In: Kuete V, editor. Advances in Botanical Research. Academic Press; 2023. pp. 1\u201320. (African Flora to Fight Bacterial Resistance, Part I: Standards for the Activity of Plant-Derived Products; vol. 106). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0065229622000994. Cited 2025 May 25.","DOI":"10.1016\/bs.abr.2022.08.001"},{"issue":"5","key":"4519_CR11","doi-asserted-by":"publisher","first-page":"e0285170","DOI":"10.1371\/journal.pone.0285170","volume":"18","author":"AN Poudel","year":"2023","unstructured":"Poudel AN, Zhu S, Cooper N, Little P, Tarrant C, Hickman M, et al. The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS ONE. 2023;18(5):e0285170.","journal-title":"PLoS ONE"},{"key":"4519_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jgar.2019.05.024","volume":"19","author":"M Ahmad","year":"2019","unstructured":"Ahmad M, Khan AU. Global economic impact of antibiotic resistance: A review. J Glob Antimicrob Resist. 2019;19:313\u20136.","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"4519_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40258-022-00728-x","volume":"20","author":"NT Hillock","year":"2022","unstructured":"Hillock NT, Merlin TL, Turnidge J, Karnon J. Modelling the future clinical and economic burden of antimicrobial resistance: the feasibility and value of models to inform policy. Appl Health Econ Health Policy. 2022;20(4):479\u201386.","journal-title":"Appl Health Econ Health Policy"},{"issue":"12","key":"4519_CR14","doi-asserted-by":"publisher","first-page":"e0189621","DOI":"10.1371\/journal.pone.0189621","volume":"12","author":"RC Founou","year":"2017","unstructured":"Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PLoS ONE. 2017;12(12):e0189621.","journal-title":"PLoS ONE"},{"issue":"4","key":"4519_CR15","first-page":"35","volume":"89","author":"L Pantea","year":"2023","unstructured":"Pantea L, Croitoru C, Burduniuc O, Balan G, Anton M. Features of the economic impact of antimicrobial resistance elucidated in scientific publications. Arta Med. 2023;89(4):35\u201345.","journal-title":"Arta Med"},{"issue":"2","key":"4519_CR16","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/S2214-109X(23)00539-9","volume":"12","author":"B Sartorius","year":"2024","unstructured":"Sartorius B, Gray AP, Weaver ND, Aguilar GR, Swetschinski LR, Ikuta KS, et al. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Glob Health. 2024;12(2):e201\u201316.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"4519_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12879-017-2713-1","volume":"17","author":"BT Tadesse","year":"2017","unstructured":"Tadesse BT, Ashley EA, Ongarello S, Havumaki J, Wijegoonewardena M, Gonz\u00e1lez IJ, et al. Antimicrobial resistance in africa: a systematic review. BMC Infect Dis. 2017;17(1):616.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"4519_CR18","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/S2214-109X(23)00587-9","volume":"12","author":"SY Essack","year":"2024","unstructured":"Essack SY, Lenglet A. Bacterial antimicrobial resistance burden in africa: accuracy, action, and alternatives. Lancet Glob Health. 2024;12(2):e171\u20132.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"4519_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/14740338.2022.2106368","volume":"21","author":"B Godman","year":"2022","unstructured":"Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia AC, Tiroyakgosi C. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future. Expert Opin Drug Saf. 2022;21(8):1089\u2013111.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"4519_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nyas.12380","volume":"1323","author":"S Kariuki","year":"2014","unstructured":"Kariuki S, Dougan G. Antibacterial resistance in sub-Saharan africa: an underestimated emergency. Ann N Y Acad Sci. 2014;1323(1):43\u201355.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4519_CR21","doi-asserted-by":"publisher","first-page":"100475","DOI":"10.1016\/j.emcon.2025.100475","volume":"11","author":"A Ripanda","year":"2025","unstructured":"Ripanda A, Rwiza MJ, Nyanza EC, Hossein M, Alfred MS, El Din Mahmoud A, et al. Ecological consequences of antibiotics pollution in sub-Saharan africa: Understanding sources, pathways, and potential implications. Emerg Contam. 2025;11(2):100475.","journal-title":"Emerg Contam"},{"issue":"20","key":"4519_CR22","doi-asserted-by":"publisher","first-page":"e39434","DOI":"10.1016\/j.heliyon.2024.e39434","volume":"10","author":"SA Hassan","year":"2024","unstructured":"Hassan SA, Mohamed Dirie A, Ahmed NR, Omar AI. Update on antimicrobial resistance in somalia: current status, challenges, opportunities, and future perspectives. Heliyon. 2024;10(20):e39434.","journal-title":"Heliyon"},{"key":"4519_CR23","doi-asserted-by":"publisher","first-page":"ohcs202300025","DOI":"10.1079\/cabionehealth.2023.0025","volume":"2023","author":"HA Hussein","year":"2023","unstructured":"Hussein HA, Abdi SM, Ahad AA. Factors and challenges contributing to antimicrobial resistance in East African pastoral settings and importance of one health approach. CABI One Health. 2023;2023:ohcs202300025.","journal-title":"CABI One Health"},{"issue":"7","key":"4519_CR24","doi-asserted-by":"publisher","first-page":"e0009529","DOI":"10.1371\/journal.pntd.0009529","volume":"15","author":"K Loosli","year":"2021","unstructured":"Loosli K, Davis A, Muwonge A, Lembo T. Addressing antimicrobial resistance by improving access and quality of care\u2014A review of the literature from East Africa. PLoS Negl Trop Dis. 2021;15(7):e0009529.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"4519_CR25","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1016\/S2542-5196(18)30186-4","volume":"2","author":"P Collignon","year":"2018","unstructured":"Collignon P, Beggs JJ, Walsh TR, Gandra S, Laxminarayan R. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. Lancet Planet Health. 2018;2(9):e398\u2013405.","journal-title":"Lancet Planet Health"},{"issue":"1","key":"4519_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/jgid.jgid_110_18","volume":"11","author":"A Chokshi","year":"2019","unstructured":"Chokshi A, Sifri Z, Cennimo D, Horng H. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11(1):36.","journal-title":"J Glob Infect Dis"},{"issue":"4","key":"4519_CR27","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S2542-5196(23)00026-8","volume":"7","author":"K Allel","year":"2023","unstructured":"Allel K, Day L, Hamilton A, Lin L, Furuya-Kanamori L, Moore CE, et al. Global antimicrobial-resistance drivers: an ecological country-level study at the human\u2013animal interface. Lancet Planet Health. 2023;7(4):e291\u2013303.","journal-title":"Lancet Planet Health"},{"issue":"2","key":"4519_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21010\/Ajidv16i2S.4","volume":"16","author":"AA Moussa","year":"2022","unstructured":"Moussa AA, Garba B. How misuse of antimicrobial agents is exacerbating the challenges facing somalia\u2019s public health. Afr J Infect Dis. 2022;16(2):26\u201332.","journal-title":"Afr J Infect Dis"},{"key":"4519_CR29","doi-asserted-by":"publisher","first-page":"7733","DOI":"10.2147\/IDR.S390886","volume":"15","author":"IM Ali","year":"2022","unstructured":"Ali IM, Duman C, Bozda\u011f \u0130, Abdi AA, Abdi MN, Karakurt SE, et al. Microbiology and drug susceptibility pattern of bacterial isolates from patients with chronic suppurative otitis media at a tertiary care hospital in Somalia. Infect Drug Resist. 2022;15:7733\u20139.","journal-title":"Infect Drug Resist"},{"issue":"s7","key":"4519_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1532-5415.50.7s.2.x","volume":"50","author":"TT Yoshikawa","year":"2002","unstructured":"Yoshikawa TT. Antimicrobial resistance and aging: beginning of the end of the antibiotic era? J Am Geriatr Soc. 2002;50(s7):226\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"4519_CR31","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3390\/microorganisms12101978","volume":"12","author":"N Theodorakis","year":"2024","unstructured":"Theodorakis N, Feretzakis G, Hitas C, Kreouzi M, Kalantzi S, Spyridaki A, et al. Antibiotic resistance in the elderly: Mechanisms, risk Factors, and solutions. Microorganisms. 2024;12(10):1978.","journal-title":"Microorganisms"},{"issue":"9","key":"4519_CR32","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/antibiotics10091098","volume":"10","author":"M Gajd\u00e1cs","year":"2021","unstructured":"Gajd\u00e1cs M, \u00c1br\u00f3k M, L\u00e1z\u00e1r A, Buri\u00e1n K. Urinary tract infections in elderly patients: A 10-Year study on their epidemiology and antibiotic resistance based on the WHO Access, Watch, reserve (AWaRe) classification. Antibiotics. 2021;10(9):1098.","journal-title":"Antibiotics"},{"issue":"9","key":"4519_CR33","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/jac\/dkv147","volume":"70","author":"A Huttner","year":"2015","unstructured":"Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015;70(9):2456\u201364.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4519_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-025-00715-9","volume":"11","author":"M Salehi","year":"2025","unstructured":"Salehi M, Laitinen V, Bhanushali S, Bengtsson-Palme J, Collignon P, Beggs JJ, et al. Gender differences in global antimicrobial resistance. Npj Biofilms Microbiomes. 2025;11(1):1\u20139.","journal-title":"Npj Biofilms Microbiomes"},{"key":"4519_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijid.2016.08.015","volume":"51","author":"DS Lee","year":"2016","unstructured":"Lee DS, Choe HS, Kim HY, Yoo JM, Bae WJ, Cho YH, et al. Role of age and sex in determining antibiotic resistance in febrile urinary tract infections. Int J Infect Dis. 2016;51:89\u201396.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"4519_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2296-14-25","volume":"14","author":"JC McGregor","year":"2013","unstructured":"McGregor JC, Elman MR, Bearden DT, Smith DH. Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients. BMC Fam Pract. 2013;14(1):25.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"4519_CR37","doi-asserted-by":"publisher","first-page":"e1004301","DOI":"10.1371\/journal.pmed.1004301","volume":"21","author":"NR Waterlow","year":"2024","unstructured":"Waterlow NR, Cooper BS, Robotham JV, Knight GM. Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: an observational study. PLOS Med. 2024;21(3):e1004301.","journal-title":"PLOS Med"},{"key":"4519_CR38","doi-asserted-by":"crossref","unstructured":"Bazira J, Nakimuli NC, Nalumaga PP, Nakazibwe B, Walekhwa AW, Simon K et al. Uncovering Gender Dimensions in Antimicrobial Resistance: A 10-Year Study of Clinical Bacterial Isolates in Uganda. medRxiv; 2025. p. 2025.04.09.25325544. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2025.04.09.25325544v1. Cited 2025 May 23.","DOI":"10.1101\/2025.04.09.25325544"},{"issue":"1","key":"4519_CR39","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1186\/s12879-023-08803-x","volume":"23","author":"BT Regassa","year":"2023","unstructured":"Regassa BT, Tosisa W, Eshetu D, Beyene D, Abdeta A, Negeri AA, et al. Antimicrobial resistance profiles of bacterial isolates from clinical specimens referred to Ethiopian public health institute: analysis of 5-year data. BMC Infect Dis. 2023;23(1):798.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4519_CR40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s13104-019-4604-6","volume":"12","author":"M Abebe","year":"2019","unstructured":"Abebe M, Tadesse S, Meseret G, Derbie A. Type of bacterial isolates and antimicrobial resistance profile from different clinical samples at a referral Hospital, Northwest ethiopia: five years data analysis. BMC Res Notes. 2019;12(1):568.","journal-title":"BMC Res Notes"},{"issue":"2","key":"4519_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijantimicag.2018.04.021","volume":"52","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang Y, Wang F, Wang C, Chen L, Liu H, et al. Unravelling mechanisms of Nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates. Int J Antimicrob Agents. 2018;52(2):226\u201332.","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"4519_CR42","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1089\/mdr.2019.0044","volume":"26","author":"A Das","year":"2020","unstructured":"Das A, Banerjee T, Anupurba S. Susceptibility of Nitrofurantoin and fosfomycin against outpatient urinary isolates of Multidrug-Resistant enterococci over a period of 10 years from India. Microb Drug Resist. 2020;26(12):1509\u201315.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"4519_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/ijmr.IJMR_2086_17","volume":"149","author":"AU Amladi","year":"2019","unstructured":"Amladi AU, Abirami B, Devi SM, Sudarsanam TD, Kandasamy S, Kekre N, et al. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, Nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res. 2019;149(2):185.","journal-title":"Indian J Med Res"},{"issue":"10","key":"4519_CR44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cmi.2015.05.022","volume":"21","author":"CG Giske","year":"2015","unstructured":"Giske CG. Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, Mecillinam and Nitrofurantoin. Clin Microbiol Infect. 2015;21(10):899\u2013905.","journal-title":"Clin Microbiol Infect"},{"key":"4519_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/IDR.S398387","volume":"16","author":"NM Sheikh Omar","year":"2023","unstructured":"Sheikh Omar NM, Erismis B, Muse Osman M, Garba B, Hassan MA, Akuku IG. Retrospective Evaluation of Nosocomial Bacterial Infections and Their Antimicrobial Resistance Patterns Among Hospitalized Patients in Mogadishu, Somalia. Infect Drug Resist. 2023;16:705\u201320.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"4519_CR46","doi-asserted-by":"publisher","first-page":"e0212131","DOI":"10.1371\/journal.pone.0212131","volume":"14","author":"FK Wangai","year":"2019","unstructured":"Wangai FK, Masika MM, Lule GN, Karari EM, Maritim MC, Jaoko WG, et al. Bridging antimicrobial resistance knowledge gaps: the East African perspective on a global problem. PLoS ONE. 2019;14(2):e0212131.","journal-title":"PLoS ONE"},{"issue":"12","key":"4519_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.7196\/SAMJ.4186","volume":"100","author":"M Moyo","year":"2010","unstructured":"Moyo M, Aboud S, Kasubi M, Maselle SY. Bacteria isolated from bloodstream infections at a tertiary hospital in Dar Es Salaam, Tanzania \u2013 antimicrobial resistance of isolates. S Afr Med J. 2010;100(12):835\u20138.","journal-title":"S Afr Med J"},{"key":"4519_CR48","doi-asserted-by":"publisher","first-page":"100717","DOI":"10.1016\/j.ijregi.2025.100717","volume":"16","author":"SA Hassan","year":"2025","unstructured":"Hassan SA, Mohamed MA, Salad ZA, Mohamed ND, Ahmed FA, Dirie FA, et al. Prevalence of methicillin-resistant Staphylococcus aureus and associated factors from surgical ward inpatients at Shaafi Hospital, Mogadishu, Somalia. IJID Reg. 2025;16:100717.","journal-title":"IJID Reg"},{"key":"4519_CR49","doi-asserted-by":"crossref","unstructured":"Aweis ADH, Ga\u2019al H, Ishaq Aweis DM, Hassan GD. Nasal carriage of methicillin-resistant Staphylococcus aureus in healthcare workers at Banadir Hospital, Mogadishu, Somalia. Front Trop Dis. 2025;6. Available from: https:\/\/www.frontiersin.org\/journals\/tropical-diseases\/articles\/10.3389\/fitd.2025.1425042\/full. Cited 2025 Oct 8.","DOI":"10.3389\/fitd.2025.1425042"},{"key":"4519_CR50","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s40001-023-01303-3","volume":"28","author":"M Mobarak-Qamsari","year":"2023","unstructured":"Mobarak-Qamsari M, Jenaghi B, Sahebi L, Norouzi-Shadehi M, Salehi MR, Shakoori-Farahani A, et al. Evaluation of acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus respiratory tract superinfections among patients with COVID-19 at a tertiary-care hospital in Tehran, Iran. Eur J Med Res. 2023;28:314.","journal-title":"Eur J Med Res"},{"issue":"3","key":"4519_CR51","doi-asserted-by":"publisher","first-page":"e02252","DOI":"10.1128\/AAC.02252-16","volume":"61","author":"HS Sader","year":"2017","unstructured":"Sader HS, Huband MD, Castanheira M, Flamm RK. Pseudomonas aeruginosa antimicrobial susceptibility results from four years (2012 to 2015) of the international network for optimal resistance monitoring program in the united States. Antimicrob Agents Chemother. 2017;61(3):e02252\u201316.","journal-title":"Antimicrob Agents Chemother"},{"key":"4519_CR52","doi-asserted-by":"crossref","unstructured":"Thabit AK, Alghamdi AM, Miaji MY, Alharbi FS, Jawah AF, Alturki F et al. Antibiotic susceptibility of Pseudomonas aeruginosa in Saudi Arabia: a national antimicrobial resistance surveillance study. Front Public Health. 2024;12. Available from: https:\/\/www.frontiersin.org\/journals\/public-health\/articles\/10.3389\/fpubh.2024.1436648\/full. Cited 2025 May 25.","DOI":"10.3389\/fpubh.2024.1436648"},{"issue":"8","key":"4519_CR53","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1128\/AAC.01165-05","volume":"50","author":"VH Tam","year":"2006","unstructured":"Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006;50(8):2626\u201331.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4519_CR54","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3343\/alm.2018.38.2.176","volume":"38","author":"YA Kim","year":"2018","unstructured":"Kim YA, Park YS, Youk T, Lee H, Lee K. Correlation of aminoglycoside consumption and Amikacin- or Gentamicin-Resistant Pseudomonas aeruginosa in Long-Term nationwide analysis: is antibiotic cycling an effective policy for reducing antimicrobial resistance? Ann Lab Med. 2018;38(2):176\u20138.","journal-title":"Ann Lab Med"},{"key":"4519_CR55","doi-asserted-by":"publisher","first-page":"e2084","DOI":"10.54034\/mic.e2084","volume":"4","author":"A Gupta","year":"2024","unstructured":"Gupta A, Sharma B. Nitrofurantoin susceptibility profile versus other antibiotics tested in uropathogens- a retrospective study from India. Microbes Infect Chemother. 2024;4:e2084\u20132084.","journal-title":"Microbes Infect Chemother"},{"key":"4519_CR56","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.2147\/IDR.S353818","volume":"15","author":"M Joya","year":"2022","unstructured":"Joya M, Aalemi A, Khalid, Baryali AT. Prevalence and antibiotic susceptibility of the common bacterial uropathogen among UTI patients in French medical Institute for children. Infect Drug Resist. 2022;15:4291\u20137.","journal-title":"Infect Drug Resist"},{"key":"4519_CR57","doi-asserted-by":"crossref","unstructured":"Mohamed AH, Mohamud MFY, Mohamud HA. Epidemiology and Antimicrobial Susceptibility Pattern of Uropathogens in Patients with the Community- and Hospital-Acquired Urinary Tract Infections at a Tertiary Hospital in Somalia. Jundishapur Journal of Microbiology; 2020. Report No.: 13. Available from: https:\/\/brieflands.com\/articles\/jjm-107453#abstract. Cited 2025 May 25.","DOI":"10.5812\/jjm.107453"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04519-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04519-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04519-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:08:06Z","timestamp":1764173286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04519-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4519"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04519-x","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Jazeera University Ethical Review Committee. The study adhered to the principles of the Declaration of Helsinki. The need for written informed consent was waived by the Jazeera University Ethical Review Committee in accordance with CIOMS International Ethical Guidelines (2016, Guideline 10) and Declaration of Helsinki (2013, Paragraph 32), as this study involved anonymized retrospective data with no patient identifiers. Data were handled confidentially, with no identifiable patient information included in the analysis or reporting.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"779"}}